ORMP insider receives 599,000 shares in stock awards
By AlphaYouPublished Form 4
Kidron Miriam
Reporting filer
Kidron Miriam reported 599,000 shares of Common Stock in ORAMED PHARMACEUTICALS INC. as grants or awards dated 2026-11-12. The Form 4 was disclosed on Nov 14, 2026. These were stock awards, not open-market purchases.
- Disclosed
- Nov 14, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Kidron Miriam | 2026-11-12 | A | Grant or award | 357000 | Not stated (see footnotes) | 1,907,554 | 2 days | Filed terms
|
| Common Stock | Kidron Miriam | 2026-11-12 | A | Grant or award | 242000 | Not stated (see footnotes) | 2,149,554 | 2 days | Filed terms
|
Common Stock
- Owner
- Kidron Miriam
- Date
- 2026-11-12
- Code
- A
- Action
- Grant or award
- Quantity
- 357000
- Price
- Not stated (see footnotes)
- Following holdings
- 1,907,554
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-12
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 357000
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 1907554
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Kidron Miriam
- Date
- 2026-11-12
- Code
- A
- Action
- Grant or award
- Quantity
- 242000
- Price
- Not stated (see footnotes)
- Following holdings
- 2,149,554
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-12
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 242000
- id: F2
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 2149554
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Kidron Miriam: Chief Scientific Officer, Director.
- F1: On November 12, 2026, the issuer granted to the reporting person a restricted stock award of 357,000 shares under the issuer's Amended and Restated 2019 Stock Incentive Plan. The shares vest only if the issuer's return on equity for fiscal year 2026 exceeds 18%, in which case 50% vest on the date the issuer's audited fiscal year 2026 financial statements are published and 50% vest six months thereafter, subject to the reporting person's continued service. If the condition is not met, all of the shares will be forfeited.
- F2: On November 12, 2026, the issuer granted to the reporting person a restricted stock award of 242,000 shares under the issuer's Amended and Restated 2019 Stock Incentive Plan, representing the reporting person's annual awards for fiscal years 2027 and 2028. Of these shares, 121,000 vest in twelve substantially equal quarterly installments beginning January 1, 2027, and 121,000 vest in twelve substantially equal quarterly installments beginning January 1, 2028, in each case subject to the reporting person's continued service. No annual award will be granted to the reporting person for fiscal year 2028.
Original sources
Prepared automatically from public filing data. Report a correction.